G9839
HCPCSAnti-egfr mon anti ther
Official HCPCS Level II long descriptor
Anti-egfr monoclonal antibody therapy
HCPCS Level II code G9839 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Anti-egfr mon anti ther
Added to HCPCS: 2017-01-01
Nearby codes in G9
- G9821No doc chlam scr ts w/follow
- G9822Endo abl proc yr prev ind dt
- G9823Endo smpl/hyst bx res doc
- G9824Endo smpl/hyst bx res no doc
- G9830Her-2 pos
- G9831Ajcc stg brt ca dx ii or iii
- G9832Br ca stg = 1 t stg = t1c
- G9838Pt met dis at dx
- G9840Gene testing performed
- G9841Gene testing not performed
- G9842Pt met dis at dx
- G9843Kras or nras gene mutation
- G9844Pt no recd anti-egfr ther
- G9845Pt recd anti-egfr ther
- G9846Pt died from cancer
- G9847Pt recd chemo last 14d life
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.